Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]

BACKGROUND: Local control in adjuvant/definitive RT of adenoid cystic carcinoma (ACC) is largely dose-dependent leading to the establishment of particle therapy in this indication. However, even modern techniques leave space for improvement of local control by intensification of local treatment. Rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Alexandra D, Nikoghosyan, Anna, Hinke, Axel, Debus, Jürgen, Münter, Marc W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042975/
https://www.ncbi.nlm.nih.gov/pubmed/21320355
http://dx.doi.org/10.1186/1471-2407-11-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042975/
https://www.ncbi.nlm.nih.gov/pubmed/21320355
http://dx.doi.org/10.1186/1471-2407-11-70

Ejemplares similares